No Data
No Data
Disc Medicine Is Maintained at Buy by Stifel
Stifel Maintains Disc Medicine(IRON.US) With Buy Rating, Raises Target Price to $90
A Quick Look at Today's Ratings for Disc Medicine(IRON.US), With a Forecast Between $70 to $118
Express News | Disc Medicine Inc : Stifel Raises Target Price to $90 From $79
Disc Medicine (IRON) Gets a Buy From Wells Fargo
Promising Pipeline Developments Bolster Buy Rating for Disc Medicine
No Data
far008 : $Vast Renewables (VSTE.US)$ has no short shares. we should see an uptick
103822628 : Sorry , unusual volume ticks means wat?
Stock_Drift OP 103822628 : Look at the volume. It’s unusual